The proposed ban on forever chemicals (or PFAS) could force the pharmaceutical industry to move production out of Europe, leading to a shortage of 600 critical medicines, the industry claims – while campaigners are calling for the restrictions to be implemented without delay.
In 2020, under the Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.To read this story, log in or subscribe
Staffan Dahllöf is a freelance reporter based in Copenhagen.
Staffan Dahllöf is a freelance reporter based in Copenhagen.